Iveda Solutions
IVDA · NASDAQ
About IVDA
- Employees
- 32
- Headquarters
- Mesa, Arizona
- Listed
- Nov 19, 2007
- Sector
- Information Technology
- Industry
- Software
- Website
- iveda.com
IVDA key statistics
- Market cap
- 2.88M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 262.04K
- Volume
- 180.74K
- Open price
- $0.228
- High today
- $0.2321
- Low today
- $0.2191
- 52 Week high
- $1.52
- 52 Week low
- $0.211
Iveda Solutions (IVDA) at a glance
As of Oct 20, 2026, Iveda Solutions (IVDA) shares are priced at $0.2298, giving the company a market cap of 2.88M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.2191 and $0.2321. The current price is 4.9% above the day's low and 1.0% below its high.
Volume so far is 180.74K shares, below the average of 262.04K shares a day.
Over the past year Iveda Solutions has ranged from $0.211 to $1.52, and now sits 1% of the way up that range.
Iveda Solutions met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY24 it reported -$0.24 per share against an estimate of -$0.408.
IVDA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 41.2% on average.
- Q3 FY22: reported -$0.32 per share against an estimate of -$0.2448
- Q4 FY22: reported -$0.48 per share against an estimate of -$0.1632
- Q1 FY23: reported -$0.32 per share against an estimate of -$0.2448
- Q2 FY23: reported -$0.40 per share against an estimate of -$0.1632
- Q3 FY23: reported -$0.05 per share against an estimate of $0.0102
- Q4 FY23: reported -$0.56 per share against an estimate of -$0.408
- Q1 FY24: reported -$0.56 per share against an estimate of -$0.408
- Q2 FY24: reported -$0.24 per share against an estimate of -$0.408
IVDA news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Iveda and GlobalMed to Host Live IvedaAir Flight Demonstration for Government and Defense Stakeholders
- Press releaseBusiness Wire
NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance
- Press releaseBusiness Wire
IvedaAir Draws Fortune 500 Defense and Government Interest Following Launch, Advances Toward Fall Flight Demonstration
- Press releaseBusiness Wire
Iveda Launches IvedaAir: Latest RUAS Line Featuring a Gas-Powered Smart Drone, Bringing AI-Powered Aerial Intelligence to Public Safety, Maritime Security, and Emergency Response Missions
12 Information Technology Stocks Moving In Friday's After-Market Session
12 Information Technology Stocks Moving In Thursday's After-Market Session
12 Information Technology Stocks Moving In Thursday's Intraday Session
Similar companies
Companies in the same industry as Iveda Solutions
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.